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decreases in the frequencies of heterozygous (GT), and
T allele of FXIII Val34Leu in UA patients group, com-
pared with the control group assuming a protective role
of FXIII 34Leu allele against unstable angina develop-
ment. The prevalence of other studied polymorphisms;
factor V H1299R (R2), Glycoprotein IIIa Leu33Pro,PAI-1
4G/5G, MTHFR C677T polymorphisms, MTHFR
A1298C, apo B R3500Q and apo E polymorphisms; did
not differ between IHD patients and control subjects.
There was a significant positive association between
FVL and family history of IHD in AMI patients. In addi-
tion, a highest prevalence of Pl A2 in patients <35 years
of age surviving a first AMI, so that age-at-onset of AMI
was significantly affected by PlA2 (<35 years vs. 35–40).
Apo E3/E4 genotype was associated with both high total
Cholesterol (TC) and high TC/HDL ratio in UA group,
while in AMI patients, Apo E3/E4 genotype was associ-
ated with high TC/HDL ratio, and high triglycerides
levels.
Conclusions: This study has identified a positive
association for FV Leiden, Prothrombin G20210A hetero-
zygosity, and ACE (I/D) polymorphism with premature
AMI; a positive association for b-fibrinogen 455-GA poly-
morphism in UA patients; and a negative association
(protective role) for FXIII Val34Leu in UA patients. This
study may open a dooor to promised goals of new thera-
peutics and personalised medicine for premature IHD
based on single nucleotide polymorphism in well defined
groups of high risk patients (<40 years); and their
families.
http://dx.doi:10.1016/j.jsha.2013.03.107
Intrauterine first-line therapy and outcome of fetal
heterotopic tachycardia
Marouane Boukhris, Kaouathar Hakim,
Nidhal Ben Moussa, Hela M’saad, Fatma Ouarda,
Rafik Boussaada
Background: Fetal heterotopic tachycardia is associ-
ated with a high risk of congestive heart failure, fetal
hydrops and intrauterine death. Transplacental treat-
ment by antiarrhythmic agents can improve prognosis
dramatically.
Objectives: The aim of our study is to review the
management and the outcome of heterotopic tachycardia
in fetal patients treated in our center.
Methods: We reported 24 cases of heterotopic fetal
tachycardia diagnosed and treated mainly with digoxin
and/or amiodarone administered by the transplacental
way.
Results: Twenty four fetal patients were studied,
thirteen with supraventricular tachycardia, eight with
atrial flutter and three with chaotic atrial tachycardia.
Among them, eight fetuses were hydropic. All mothers
were given an antiarrythmic treatment by mouth. There
were three intrauterine deaths. Digoxin monotherapy
converted 6/8 non hydropic fetuses and 0/2 hydropic
fetuses who died. Amiodarone monotherapy converted
4/6 including 2 hydropic fetuses with one intrauterine
death. The association of digoxin and amiodarone con-
verted 7/7 fetuse including 3 hydropic patients. No death
found with this association. Propanolol was used in
monotherapy or associated with digoxin in vain in three
patients with chaotic atrial tachycardia.
Conclusions: Maternal oral antiarrhythmic treat-
ment should be given as soon as the diagnosis of fetal
heterotopic tachycardia is done. Digoxin and amiodarone
seems to be effective. Their association is particularly
indicated in hydropic fetuses.
http://dx.doi:10.1016/j.jsha.2013.03.108
Successful transcatheter closure of perimembra-
nous ventricular septal defect with inlet extension
using Amplatzer occlude device (ADOI)
Mashail Alobaidan, Abdulmajeed Alotay,
Nabeel Abdulrazaaq
Introduction: Transcatheter closure of perimembra-
nous ventricular septal defect (PM VSD) is abandoned in
many center and in some became restricted to certain age
and criteria because of the risk of complete heart block
(CHB). The risk of damaging the tricuspid valve (TV) in
the presence of inlet extension is another risk. I am pre-
senting successful closure of such defect using Amplatzer
occluder device for PDA with reasonable follow up per-
iod in Prince Sultan Cardiac Center PSCC.
Method: Through 2011 4 patients underwent trans-
catheter closure of PM VSD with inlet extension, all
patients were consented and procedure were done under
general anesthesia, Transesophageal echocardiography
was done in all, one has 3D assessment Hemodynamics
were assessed pre procedural, A–V loop was applied in
2 patients, ADOI were used in all,heparin and antibiotics
were giving during and 24 h post procedure, 3 patients
were extubated same day and one the following day, all
patients were kept on aspirin for 6 months.
Result: Median age 17 kg, 3 female and 1 male, med-
ian age 7 year, Median ventilatory duration is one day,
Median hospital stay is 2 days, Median Follow up is 16
months, No immediate or early complication or deaths,
normal ECG immediately and during follow up period,
normal Echocardiography with no residual leak during
follow up period.
Conclusion: In selected patients with PM VSD and
inlet extension ADOI device can be used safely and effec-
tively to close the defect with no immediate or early
complications.
http://dx.doi:10.1016/j.jsha.2013.03.109
Early experience on aortic arch surgery at King
Fahd Armed Forced Hospital (KFAFH), Jeddah
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Background: To our knowledge KFAFH cardiac
department is one of the few centers performing aortic
arch surgery in Saudi Arabia. The optimal strategy for
management of the circulation during aortic arch surgery
remains controversial and neurologic dysfunction due to
cerebral ischemia remains a significant concern. We
report our early experience on aortic arch surgery per-
formed with Deep or Moderate Hypothermic Circulatory
Arrest (DHCA or MHCA) and Antegrade Selective brain
Perfusion (SAP).
Patients and methods: 14 consecutive patients (pts)
underwent aortic arch repair between 2008 and 2012. 4
pts were operated on emergency basis because of type
A aortic dissection or impending rupture, 10 pts on elec-
tive basis. 5 pts (35.7%) had complete arch replacement
and 9 pts (64.3%) had emiarch repair. Axillary cannula-
tion was performed in 12 pts (85.7%), femoral cannulation
in 2 pts (14.3%). Our brain protection strategy consisted
in DHCA (18–20 C) in 11 pts (78.6%), MHCA (23–25 C)
in 3 pts (21.4%). Selective monolateral antegrade perfu-
sion (uSAP) trough axillary artery was performed in 12
pts (85.7%), selective bilateral antegrade perfusion
(bSAP) in 2 pts (14.3%). Mean circulatory arrest was
29 ± 15 min, Cerebral oximetry has been employed to
monitoring brain perfusion.
Results: In-hospital mortality rate was 0, no pt had
permanent neurological deficit. 1 pts (7.1%) had a tempo-
rary neurological deficit, 2 pts renal impairment (21.4%),
1 pt vocal cord paralysis (7.1%), 3 pts bleeding (21.4%).
Temperature was not identified as independent predictor
of transient neurological deficit (p 0.5). MHCA was signif-
icantly associated to reduced blood loss after surgery
(p < 0.01). Mean follow-up (22 months): no pt died, 1 pt
presented aortic pseudoaneurysm 6 months after surgery
(Marfan syndrome with aortic dissection).
Conclusion: Early KFAFH experience on aortic arch
surgery has been performed with very good outcome.
HCA arrest with SAP represents a very effective tech-
nique of brain protection. For short circulatory arrest
time MHCA is safe and can reduce coagulopathy prob-
lems related to DHCA.
http://dx.doi:10.1016/j.jsha.2013.03.110
Monitoring of antiaggregation therapy effectivity
inpatients with acute stemi: Is it really necessary
in clinicalpractice?
M. Samos, R. Simonova, F. Kovar, J. Stasko,
M. Mokan, P. Kubisz
Introduction: Antiaggregation therapy is the key-
stone of acute ST elevation myocardial infarction
(STEMI) drug treatment; but effectivity of this therapy
is not always sufficient. The aim of the study was to
determine wheather laboratory monitoring of antiaggre-
gation therapy helps to improve the management of
patients with acute STEMI.
Material and methods: A pilot prospective study in
patients with acute STEMI treated with direct percutane-
ous coronary intervention (dPCI) of culprit lession. Optic
aggregometry was chosen to assess the effectivity of
antiaggregation treatment. Samples were taken prior to
coronarography (sample 1) as well as at first day after
diagnostic procedure (sample 2). MACE (in-stent trom-
bosis, heart failure, in hospital death, all cases mortality,
ventricular arrhytmia, needs of repeat revascularization)
were sequently monitored. Study group included 22
patients (average age 66 years, 11 men, 11 women), from
whom 14 had recieved clopidogrel loding dose and 8 had
recieved prasugrel loding dose.
Results: In clopidogrel group 11 patients did not
reach effective drug activity in first sample and 3 patients
did not reach effective drug activity in second sample.
While in prasugrel group ineffective antiaggregation
was seen just in 1 patient in first sample. In patients with
clopidogrel treatment more MACE developed in fol-
lowed period (13 vs. 6).
Conclusion: Our results show that optic aggregome-
try seems to be a usefull laboratory method for antiaggre-
gation drugs effectivity assessment. Prasugrel treatment
seems to be more effective than clopidogrel administra-
tion in patients with acute STEMI and dPCI of culprit
lession.
http://dx.doi:10.1016/j.jsha.2013.03.111
Effectiveness of intraarterial nitrate for transradial
coronary angiography
Abu Salim, Syed Ali Ahsan, K.M.H.S. Sirajul
Haque, P.C. Rath, Vbpurohit
Background: Transradial access is a well established
approach for coronary angiography and percutaneous
coronary intervention. However a major pitfall is radial
artery vasospasm, for which several pharmacological
agents are being considered. We have used 100 micro-
gram intra-arterial glycerine trinitrate (GTN) only to
counter this problem.
Method: A study was done in Bangabandhu Sheikh
Mujib Medical University (BSMMU), Dhaka, Bangladesh
and Apollo Hospital, Hyderabad, India from January 2102
to June 2012. Total 80 patients (40 patient in GTN group
and 40 patients in GTN + Diltiazem group) were included
for CAG ± PCI. Patients were randomized into 2 groups
to compare intraarterial GTN and a combination of
GTN+Diltiazem. Radial artery spasm and patient comfort
were assessed in both groups.
Results: Radial artery spasm leading to femoral
access was statistically insignificant comparing both
groups. None of the patients in GTN group had pain or
burning sensation during administration, whereas the
cocktail group (GTN + Diltiazem) had some discomfort
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